July 12, 2011

Elsevier Launches Current Opinion in Virology

AMSTERDAM, July 12, 2011 /PRNewswire/ --

- Helping Virologists Keep Up-to-Date in a Fast-moving Field

Elsevier (http://www.elsevier.com) has announced the publication of the
first issue of Current Opinion in Virology - a new journal in its
prestigious Current Opinion series, publishing six issues a year. Current
Opinion in Virology was launched to provide a systematic, comprehensive and
filtered approach to the ever-expanding wealth of research published on
viruses and viral interaction: a platform to help busy specialists keep
up-to-date with the latest trends and topics in virology research. The
journal publishes invited review papers only and is divided into twelve
annual sections, including viral genomics, antivirals and resistance,
emerging viruses and virus evolution.

The editorial board is led by Editors in Chief Mary Estes (Baylor
College of Medicine, USA) and Ab Osterhaus (Erasmus MC, The Netherlands).
"Virology is a discipline that is dynamic, multidisciplinary and important
to our lives in many ways," states Dr. Estes. "When approached about
starting a new journal in virology, we came to the conclusion that the
principle and quality of the Current Opinion series in other topics made it
an attractive medium to communicate new information in a broad range of
virology topics. Looking beyond the successful launch of the journal," Dr
Estes concluded, "we look forward, as the virology field, technologies and
world continues to change, to Current Opinion in Virology becoming one of
the most highly respected journals in the field."

All articles in the first issue are freely available online
(http://www.sciencedirect.com/science/journal/18796257 ). More
information on the journal can be found on the website

About Elsevier

Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock

        Media Contact
        Alina Helsloot
        [email protected]
        Phone +31-20-485-3835

SOURCE Elsevier